Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Discovery & Development

Discovery & Development Small Molecules

Solutions in... Drug Development

| James Strachan

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

Discovery & Development Formulation

In Conversation with Jeanne Thoma of SPI Pharma

| James Strachan

The Medicine Maker speaks with Jeanne Thoma, President and CEO from SPI Pharma

Discovery & Development Formulation

Owner of a Lonely Heart

| Jessica Finlay

In 2018, the UK’s government appointed its first Minister for Loneliness. The role: to tackle loneliness.

Discovery & Development Ingredients

In Conversation with Christophe Le Ret of Umicore

| James Strachan

The Medicine Maker speaks with Christophe Le Ret, Global Marketing Director of Umicore

Discovery & Development Drug Discovery

The (Secret) Barrier Breaker

| Maryam Mahdi

Sitting Down With… Steve Arlington, President at the Pistoia Alliance.

Discovery & Development Small Molecules

Remembering Stewart Adams OBE

| Stephanie Sutton

The inventor of ibuprofen died on January 30, aged 95.

Discovery & Development Drug Discovery

RePURPOSED

| Maryam Mahdi

Recycled and reused: scientists develop a library to help teach old drugs new tricks.

Discovery & Development Formulation

Taking a Byte out of Formulation Development

| Ronak Savla, Julien Meissonnier, Jan Neelissen

With so much technology at our disposal, it’s time to get smart in formulation by adopting in silico approaches.

Discovery & Development Contract Development Services

In Conversation with Michel Legarde of Thermo Fisher Scientific

| James Strachan

The Medicine Maker speaks with Michel Legarde, President of Pharmaceutical Services, Patheon, part of Thermo Fisher Scientific.

Discovery & Development Contract Development Services

In Conversation with Nick Shackley of Johnson Matthey

| James Strachan

The Medicine Maker speaks with Nick Shackley, VP of Johnson Matthey

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register